• Nenhum resultado encontrado

[PDF] Top 20 Rev. Bras. Hematol. Hemoter. vol.39 número4

Has 10000 "Rev. Bras. Hematol. Hemoter. vol.39 número4" found on our website. Below are the top 20 most common "Rev. Bras. Hematol. Hemoter. vol.39 número4".

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Urinary concentrating ability in patients with Jk(a-b-) blood type who lack carrier-mediated urea transport. Caprioli TV, Visentainer J, Sell AM[r] ... See full document

2

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Complete remission of multiple myeloma after auto immune hemolytic anemia: possible association with interferon-␣.[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival. Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, Ande[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... The median age of the nine patients with isolated del(17p) was 52 (range: 45–82) years, the median age of the three patients with isolated del(6q) was 46 (range: 43–58) years and for the two patients with del(11q) ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... In “Copy number state”, line in 2.00 indicates a normal copy number (diploid), line in 1.00 indicates a deletion and line in 3.00 indicates a duplication/gain.. In “Allele Difference”, t[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... The major advan- tage of SNP-A over metaphase cytogenetic analysis is its ability to detect hidden chromosomal defects, including submicro- scopic (cryptic) aberrations and the distincti[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Antigen negative units would be provided by IAT crossmatch using DTT treated donor RBCs.. 8 Also, we have provided the patient with an information card indicating his treatment with dara[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... In autosomal recessive osteopetrosis (AROP), the most common mutation (60%) is seen in the TCIRG1 gene affecting the proton pump function involved in acidification of resorp- tion lacuna[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Important genes such as CEBPB, which plays a pivotal role in proliferation and differentiation, including sup- pression of myeloid leukemogenesis, 7 RARA, which is required for optimal m[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review. Transfus Med Rev[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... However, it is important to note that restarting imatinib can only be considered in the context of initial deep molecular responses being achieved by a second generation TKI or if the BC[r] ... See full document

4

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... splenectomy can lead to thromboembolic events, particularly in splenectomized patients with thalassemia intermedia.. 1,2.[r] ... See full document

3

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... This syndrome results from several factors related to the aircraft cabin (immobilization, hypo- baric hypoxia and low humidity) and the passenger (body mass index, thrombophilia, oral co[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Bone mineral density, vitamin D, and nutritional status of children submitted to hematopoietic stem cell transplantation.[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Due to the similarity between allergic hypersensitivity reactions and non-allergic hypersensitivity reactions and hyperammonemia, the differential diagnosis of the reactions related to a[r] ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Main results: One hundred and twenty-eight patients were analyzed. The mean age was 28.5 years. The five-year progression-free and overall survival were 37.3% and 78.9%, respectively. Of the whole group, 55 (43%) were ... See full document

6

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Results: Almost half (48.3%) of the transplanted adult patients were underweight consider- ing body mass index whereas eutrophic status was observed in 66.7% of the children and adolesce[r] ... See full document

7

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... Parameters such as MCV, RDW-CV, RDW-SD, MCHC, differ- ential counts of neutrophils and suspect flags displayed the highest positive predictive values. Thus, appropriate adjust- ments to the cut-off limits of these ... See full document

12

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... This study evaluated the distribution of the Kidd phenotypes in patients with chronic kidney disease and a possible association of Kidd antigens with the development of renal disease.. M[r] ... See full document

5

Rev. Bras. Hematol. Hemoter.  vol.39 número4

Rev. Bras. Hematol. Hemoter. vol.39 número4

... 13. Jaime-Pérez JC, Gamboa-Alonso CM, Padilla-Medina JR, Jiménez-Castillo RA, Olguín-Ramírez LA, Gutiérrez-Aguirre CH, et al. High frequency of primary refractory disease and low progression-free survival rate of Hodgkin ... See full document

2

Show all 10000 documents...